Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Portfolio Pulse from Avi Kapoor
ASLAN Pharmaceuticals shares dropped over 38% after announcing the voluntary liquidation of its sole operating subsidiary. Other notable stock movements include Aptevo Therapeutics climbing 84% following a $2.75 million offering, and Shimmick Corporation rising 49% after securing a $27.6 million subcontract. Cassava Sciences fell nearly 30% due to executive leadership changes.
July 17, 2024 | 5:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ASLAN Pharmaceuticals shares fell 38.7% to $0.68 after announcing the voluntary liquidation of its sole operating subsidiary.
The announcement of voluntary liquidation is a significant negative event, leading to a sharp decline in share price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Cassava Sciences shares fell 29.8% to $9.51 after announcing changes in executive leadership.
Changes in executive leadership can create uncertainty, leading to a significant decline in share price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 60
POSITIVE IMPACT
Aptevo Therapeutics shares climbed 84% to $0.6073 after closing a $2.75 million offering.
The successful closing of a $2.75 million offering is a positive development, leading to a significant increase in share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
POSITIVE IMPACT
Shimmick Corporation shares climbed 49% to $3.0173 after receiving a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.
Securing a substantial subcontract is a positive event, leading to a significant increase in share price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 70